The Diabetic Drug Supports Weight Loss

The clinical trials conducted to test the safety and efficiency of the diabetes drugs, glucagon-like peptide-1 receptor (GLP-1R) found it to be effective in providing obese patient weight loss solutions too. The results showed an effective weight loss solution to the patients irrespective of whether they are the sufferers of diabetes.

The clinical trial operated included 6,411 adults. The participants were given at clinically relevant doses for at least 20 weeks. The subjects observed significant weight loss in the clinical trial. Researchers warned that there is still more research has to be carried out on cardiovascular disease comorbidities before it is recommended for weight loss.